Sport and exercise medicine (SEM) is a fast-evolving discipline that relies on good science to guide best practice. An area that has garnered great interest among SEM clinicians and patients is the use of platelet-rich plasma (PRP) as a clinical intervention. PRP is increasingly used in a range of musculoskeletal conditions and injuries that are often unresponsive to standard therapies. PRP’s biological profile and accompanying minimal side effects make it an especially appealing modality. In several countries, it is also easily accessible for both doctor and patient and relatively affordable. However, as is often the case in medicine, and for a combination of these reasons, the use of PRP in many clinical scenarios has outstripped the science supporting its efficacy. One such condition is chronic Achilles tendinopathy, where studies investigating the use of PRP have resulted in conflicting results with insufficient definitive guidance.1–3 To allow us to understand the efficacy of PRP in Achilles tendinopathy we require high-quality, well-controlled interventional studies peer reviewed by expert, experienced clinician–scientists and published in reputable journals. The recent study by Kearney et al , ‘Effect of …

中文翻译：

---

PRP 在运动和运动医学中的应用：警惕科学成为骗局

运动与运动医学 (SEM) 是一门快速发展的学科，它依靠良好的科学来指导最佳实践。在 SEM 临床医生和患者中引起极大兴趣的一个领域是使用富血小板血浆 (PRP) 作为临床干预措施。PRP 越来越多地用于一系列通常对标准疗法无反应的肌肉骨骼疾病和损伤。PRP 的生物学特征和伴随的最小副作用使其成为一种特别吸引人的方式。在一些国家，医生和患者都可以轻松获得它，而且价格相对实惠。然而，正如医学中经常发生的情况一样，由于这些原因的结合，PRP 在许多临床场景中的使用已经超过了支持其功效的科学。其中一种情况是慢性跟腱病，调查 PRP 使用的研究导致结果相互矛盾，缺乏明确的指导。1-3 为了让我们了解 PRP 在跟腱病中的疗效，我们需要由专家、经验丰富的临床医生同行评审的高质量、控制良好的介入研究– 科学家并在著名期刊上发表。Kearney 等人最近的研究“……的影响”